Clinical Trial Update: Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates on adjuvant bortezomib maintenance after autologous stem cell transplantation in intermediate/advanced multiple myeloma (Phase 1/Phase 2)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-03-15